Nipple-Areolar Complex Matrix

About Novothelium

NovoThelium is a private, pre-clinical stage biotech focused on revolutionizing a specific niche in breast cancer reconstruction: nipple regeneration. The company's platform creates a biocompatible, donor-derived nipple-areolar matrix designed to be grafted onto the breast, where it acts as a natural scaffold for the patient's own cells to repopulate, potentially restoring projection, sensation, and pigmentation lost in current flap-and-tattoo methods. While the technology is not yet available for clinical use, it targets a clear unmet need among the millions of breast cancer survivors who undergo reconstruction. The company appears to be in the R&D and early team-building phase, led by its scientific co-founders.

Therapeutic Areas